0054-0470 : Everolimus .25 mg Oral Tablet


NDC0054-0470
Labeler: Hikma Pharmaceuticals USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Everolimus
Dosage Form: Oral Tablet
Application #: ANDA206133
Rev. Date: 


NDC Package Codes:

  • 0054-0470-21: 60 TABLET IN 1 BOTTLE (0054‑0470‑21)

Active Ingredients:

  • Everolimus

Dosage Strength:

  • .25 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • mTOR Inhibitor Immunosuppressant [EPC]
  • mTOR Inhibitors [MoA]
  • Decreased Immunologic Activity [PE]

Related Products:

Based on records with the same trade name.
  • 0054-0471 Everolimus .5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0472 Everolimus .75 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0480 Everolimus 2.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0481 Everolimus 5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0497 Everolimus 7.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0093-7766 Everolimus 2.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7767 Everolimus 5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7768 Everolimus 7.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0378-3096 Everolimus 2.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3097 Everolimus 5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-3098 Everolimus 7.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 49884-119 Everolimus 2.5 mg Oral Tablet by Par Pharmaceutical, Inc.
  • 49884-125 Everolimus 5 mg Oral Tablet by Par Pharmaceutical, Inc.
  • 49884-127 Everolimus 7.5 mg Oral Tablet by Par Pharmaceutical, Inc.
  • 51991-379 Everolimus .25 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-380 Everolimus .5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-381 Everolimus .75 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-821 Everolimus 2.5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-822 Everolimus 5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • 51991-823 Everolimus 7.5 mg Oral Tablet by Breckenridge Pharmaceutical, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0054-0470 QR Code

< Prev: 0054-0469Next: 0054-0471 >

Related Discussions:

Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.